Of these, 415 pregnancies were excluded for various reasons including incomplete data on insulin dosage or pregnancy outcome, failure to follow-up after the initial visit, miscarriage or termination of pregnancy, delivery before 28 weeks of gestation, insulin data reported as a proportion (rather than absolute units), or a diagnosis of gestational diabetes or impaired glucose tolerance. This evidence concerns the gene INS and gestational diabetes.